CAUSEY CHRISTOPHER bought UTHR
September 2, 2025 · Form 4 insider transaction
CAUSEY CHRISTOPHER bought 3,000 shares of United Therapeutics Corporation at $132.30 per share, a transaction worth $396.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,000
Price
$132.30
Total value
$396.9K
InsiderCAUSEY CHRISTOPHER
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 2, 2025
Filing dateSeptember 2, 2025
Shares owned after7,865
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.